Showing results (61-70 of 311) with videos related to
Sort By:
Pageof 32
Anticancer Research|July 1, 1988
A new look at radionuclides therapy in metastatic disease of bone (review and prospects)S I Kim, D C Chen, F M MuggiaInternational Journal of Radiation Oncology, Biology, Physics|January 1, 1984
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologiesF M Muggia, R H Blum, J D ForemanInvestigational New Drugs|January 1, 1985
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot studyR H Earhart, F M Muggia, F M GolombAnnals of Internal Medicine|January 1, 1978
Hormonal therapy of breast cancer: new approaches and conceptsS S Legha, H L Davis, F M MuggiaCancer Research|May 1, 1988
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferonM D Green, J L Speyer, H S Hochster, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.Medical and Pediatric Oncology|January 1, 1976
Overview of early and investigational chemotherapeutic agents in solid tumorsM Rozencweig, M Slavik, F M Muggia, et al.Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.Pageof 32